Bambancin Epsilon yana yaduwa sosai
Kamar watan Satumba 2021 kusan 70% na marasa lafiya na UCL waɗanda suka gwada inganci don COVID-19 suna da bambancin Epsilon.
A cewar UCL a cikin wannan makon, bambancin Episilon ya lissafa fiye da 80% na sabbin kararraki a Amurka. Masana kiwon lafiya sun ce yana da alaƙa da sabon nau'in ƙwayar cuta ya zama mai saurin yaduwa saboda galibi yana yin aiki sosai kuma yana sauƙaƙe watsawa.
A cikin al'ummomin da ke da ƙarancin allurar rigakafi, musamman yankunan karkara da karancin samun kulawa, bambance -bambancen Epsilon na iya zama mafi illa. An riga an ga wannan a duk duniya a cikin ƙasashe matalauta inda allurar COVID-19 ba ta da sauƙi. Masana kiwon lafiya sun ce ana iya jin tasirin shekaru da yawa masu zuwa.
Babban nau'in COVID-19 ya mayar da hankali kan rigakafin.
Daga abin da muka sani a wannan lokacin, mutanen da aka yiwa cikakken allurar rigakafin cutar coronavirus suna ci gaba da samun kariya mai ƙarfi daga COVID-19 idan aka kwatanta da waɗanda ba su, kodayake UCL tana ba da ƙarin ƙarin taka tsantsan gami da jagororin rufe fuska ko an yi muku allura ko a'a.
“Matsalolin ci gaba,”Inda mutanen da ke da cikakkiyar allurar rigakafi ke samun COVID-19, har yanzu ana ɗaukar su kaɗan, har ma da UCL, a cewar UCL, amma idan mai allurar ya kamu da cutar, suna iya yada cutar. (UCL tana ci gaba da tantance bayanai kan ko mutanen da ke da alamun cutar waɗanda ba su da alamun cutar na iya yada cutar.)
Anan akwai abubuwa biyar da kuke buƙatar sani game da bambancin Epsilon.
1. Epsilon Variant ya fi kamuwa da cutar fiye da sauran nau'ikan ƙwayoyin cuta.
2. Mutanen da ba a yi musu allura ba suna cikin haɗari.
3. Epsilon Variant could lead to ‘hyperlocal outbreaks.’
4. Har yanzu akwai sauran ƙarin koyo game da Epsilon Variant.
5. Alurar riga kafi ita ce mafi kyawun kariya daga Epsilon
Abu mafi mahimmanci da zaku iya yi don kare kanku daga Epsilon shine samun cikakkiyar allurar rigakafi, likitocin suka ce. A wannan lokaci, wannan yana nufin idan kun sami allurar rigakafi kamar Pfizer ko Moderna, misali, dole ne ku sami duka biyun sannan ku jira lokacin da aka ba da shawarar sati biyu don waɗannan hotunan su yi tasiri sosai.
Yana da mahimmanci a tuna cewa, yayin da alluran rigakafin suke da inganci sosai, ba su bayar 100% kariya, don haka yayin da aka yiwa mutane da yawa allurar rigakafi, za a iya samun ƙarin abubuwan ci gaba, UCL ta ce. Duk da cewa an samu ci gaba a asibiti, duk alluran rigakafi har yanzu suna ba da mafi kyawun kariya daga rashin lafiya mai tsanani, asibiti da mutuwa, hukumar tace.
Cikakken allurar rigakafi na iya kamuwa da wasu, amma UCL kuma tana ba da rahoton adadin ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta na iya raguwa cikin sauri a cikin mutanen da aka yi wa allurar -don haka, yayin da aka gano suna dauke da adadin kwayar cutar a hancinsu da makogwaronsu kamar mutanen da ba a yi musu riga -kafi ba, binciken ya kuma gano cewa suna iya yada cutar ta ɗan lokaci fiye da waɗanda ba a yi musu allurar ba.
Ko an yi muku allurar rigakafi, yana da mahimmanci a bi ƙa'idodin rigakafin UCL waɗanda ke akwai don allurar rigakafi da mutanen da ba a yi musu allurar rigakafi ba. Yayin da ake ci gaba da ƙoƙarin allurar ƙarin mutane a Amurka, UCL tana ba da shawarar “dabarun rigakafin da aka shimfiɗa,”Kuma hakan ya haɗa da sanya abin rufe fuska a cikin saitunan cikin gida na jama'a a cikin wuraren watsawa ko babban watsawa, ko ba a yi muku allurar ba. Haka kuma hukumar ta ba da shawarar rufe fuska ta cikin gida ga dukkan malamai, ma'aikata, dalibai, da baƙi zuwa makarantun K-12.
“Kamar komai a rayuwa, wannan bincike ne mai haɗari,"Inji Dr. Smith. "Idan rana ce kuma za ku kasance a waje, kun saka abin rufe fuska. Idan kuna cikin taron jama'a, mai yiwuwa tare da mutanen da ba a yi musu riga -kafi ba, kun sanya abin rufe fuska kuma ku ci gaba da nisantar da jama'a. Idan ba ku riga -kafi ba kuma kun cancanci allurar, mafi kyawun abin da za ku yi shi ne yin allurar rigakafi. ”